Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Biopreserv Biobank ; 22(1): 51-59, 2024 Feb.
Article in English | MEDLINE | ID: mdl-37192475

ABSTRACT

The objective of this study was to evaluate the effects of different concentrations of antifreeze protein (AFP) extracted from the larva of the beetle, Tenebrio molitor (TmAFP), on vitrification of in vitro-produced bovine embryos. In vitro-produced blastocysts were divided into three experimental groups and vitrified using a cryotop. TmAFP was added to the equilibrium solution (ES) and vitrification solution (VS) at a concentration of 0 ng/mL (control), 500 ng/mL (500TmAFP), or 1000 ng/mL (1000TmAFP). Vitrification was carried out by first placing the blastocysts in ES for 2 minutes (7.5% ethylene glycol [EG] and 7.5% dimethyl sulfoxide [DMSO]). The blastocysts were then transferred to VS (15% EG and 15% DMSO) and promptly deposited on a cryotop stem and submerged in liquid nitrogen. Warming was carried out in three steps with decreasing sucrose concentrations. After warming, the blast cells were cultured for 24 hours for subsequent survival analysis and ultrastructural evaluation. There was a significant difference in the survival rate and expansion in the 500TmAFP group compared with the other groups. The ultrastructural analysis revealed intracellular lesions in all vitrified embryos; however, the embryos of the 500TmAFP and 1000TmAFP groups showed fewer cytoplasmic lesions compared with the control group. Taken together, addition of TmAFP can mitigate cellular changes that involve organelles and cellular components essential for proper functioning and improve the viability of warmed and vitrified in vitro-produced bovine embryos.


Subject(s)
Tenebrio , Vitrification , Animals , Cattle , Cryopreservation , Dimethyl Sulfoxide , Cryoprotective Agents/pharmacology , Antifreeze Proteins/pharmacology , Ethylene Glycol/pharmacology
2.
Zygote ; 28(6): 495-503, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32811580

ABSTRACT

This study aimed to evaluate the relationship between antral follicular count (AFC) and ovarian volume (OV), preantral follicular population and survival, meiotic progression and ultrastructure of cumulus-oocyte complexes (COCs) after in vitro maturation. In experiment 1, the relationship between AFC and preantral follicle population and survival was evaluated by classical histology. In experiment 2, the relationship among AFC, OV, ability of oocytes to resume meiosis and ultrastructure of in vitro matured bovine COCs was studied. A positive correlation (P < 0.05) between AFC and the numbers of healthy primordial, degenerate and total follicles was observed, as well as with healthy secondary follicles and total follicles. The numbers of grades I and II oocytes in ovaries of high AFC class were higher compared with those with intermediate or lower AFC. After in vitro maturation, COCs from ovaries of high AFC had a higher percentage of oocytes in metaphase II compared with those of intermediate and low AFC (P < 0.0001). Ovaries of intermediate AFC had a higher percentage of oocytes in metaphase II compared with ovaries with low AFC (P < 0.0001). The proportion of oocytes in metaphase I, telophase I and anaphase I in COCs from ovaries of intermediate AFC (26.04%) was higher (P < 0.05) compared with that seen in COCs of ovaries with high (8.55%) and low (14.15%) AFC. No differences in the ultrastructure of oocytes were seen. In conclusion, after in vitro maturation, cow ovaries with high AFC have higher numbers of oocytes that reach in metaphase II (MII), but they also have higher numbers of degenerated primordial and primary follicles.


Subject(s)
Ovary , Animals , Cattle , Embryonic Development , Female , Meiosis , Oocytes , Ovarian Follicle
3.
Pharmacol Rep ; 69(1): 81-89, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27914293

ABSTRACT

BACKGROUND: Acute lung injury (ALI) is characterized by extensive neutrophil infiltration, and apoptosis delay considered part of the pathogenesis of the condition. Despite great advances in treatment strategies, few effective therapies are known for ALI. Diethylcarbamazine (DEC) is used against lymphatic filariasis, a number of studies have described its anti-inflammatory activities and pro-apoptotic effect. These properties have been associated with nuclear factor kappa-B inactivation. The aim of the present study was to investigate the effect of DEC on ALI induced by lipopolysaccharide (LPS) in mice. METHODS: DEC effect was evaluated by histological and ultrastructural analysis, immunohistochemistry and western blot (WB). Also TUNEL assays were performed and as well as myeloperoxidase (MPO) levels and nitric oxide (NO) were measured. RESULTS: The results demonstrate that LPS induced histological and ultrastructural changes with tissue damage, intense cell infiltration and pulmonary edema, and also increased levels of MPO and NO. DEC reversed these effects, confirming its anti-inflammatory action. DEC pro-apoptotic activity was also evaluated. The expression of TUNEL-positive cells and caspase-3 was increased in DEC treated group. Furthermore, immunohistochemical and WB analysis showed that DEC increased the expression of pro-apoptotic proteins in both the intrinsic (Bax, cytochrome c and caspase-9) and the extrinsic pathways of apoptosis (Fas, FADD and caspase-8). Additionally, DEC reduced the expression of the anti-apoptotic protein Bcl-2. CONCLUSION: Our results suggest that DEC attenuates ALI through the prevention of inflammatory cells accumulation by stimulating apoptosis. DEC accelerates the resolution of inflammation and may be a potential pharmacological treatment for ALI.


Subject(s)
Acute Lung Injury/prevention & control , Apoptosis/drug effects , Diethylcarbamazine/therapeutic use , Inflammation Mediators/antagonists & inhibitors , Lipopolysaccharides/toxicity , Acute Lung Injury/chemically induced , Acute Lung Injury/metabolism , Animals , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/therapeutic use , Apoptosis/physiology , Diethylcarbamazine/pharmacology , Inflammation/chemically induced , Inflammation/metabolism , Inflammation/prevention & control , Inflammation Mediators/metabolism , Male , Mice , Mice, Inbred C57BL
4.
Tissue Cell ; 47(5): 515-25, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26250484

ABSTRACT

Sildenafil is an important phosphodiesterase inhibitor used to treat a range of diseases, including cardiovascular disease, prostatic hyperplasia and pulmonary hypertension. Its main mechanism of action is the inhibition of phosphodiesterase 5, leading to increased intracellular cyclic guanosine 3',5'-monophosphate. This second messenger plays an interesting role in the reproductive tract. The aim of the present study was to evaluate the effect of Sildenafil on folliculogenesis and fertility in mice. To do so, C57BL/6 wild-type mice and inducible nitric oxide synthase knockout (iNOS(-/-)) mice were treated with Sildenafil, and reproductive variables were evaluated. The treated and control animals underwent estrous cycle and fertility assay. Lipid profile, serum nitric oxide levels and the expression of endothelial nitric oxide synthase, inducible nitric oxide synthase and guanylate cyclase were evaluated. Additionally, ovaries were submitted to histological and morphological analysis. The findings demonstrated that chronic treatment with Sildenafil had no effect on folliculogenesis or fertility in C57BL/6 mice, suggesting that this drug can be safely used by women of childbearing age.


Subject(s)
Fertility/drug effects , Nitric Oxide Synthase Type III/drug effects , Nitric Oxide Synthase Type II/drug effects , Sildenafil Citrate/pharmacology , Animals , Estrous Cycle/drug effects , Estrous Cycle/physiology , Mice, Inbred C57BL , Mice, Knockout , Nitric Oxide/metabolism , Nitric Oxide Synthase Type II/metabolism , Sildenafil Citrate/administration & dosage
5.
Cell Tissue Res ; 362(1): 241-51, 2015 Oct.
Article in English | MEDLINE | ID: mdl-25948481

ABSTRACT

The risk of reintroducing malignant cells after ovarian graft into patients following post-cancer treatment is an obstacle for clinical applications (autotransplantation). In this context, in vitro follicle culture would be an alternative to transplantation in order to minimize such risks. Therefore, the aim of this study was to compare the development of secondary follicles after vitrification in isolated form (without stroma) with vitrification in in situ form (within fragments of ovarian tissue). Follicles were first isolated from ovarian fragments from mixed-breed ewes and then vitrified; these comprised the Follicle-Vitrification group (Follicle-Vit), or fragments of ovarian tissue were first vitrified, followed by isolation of the follicles, resulting in the Tissue-Vitrification group (Tissue-Vit). Control and vitrified groups were submitted to in vitro culture (6 days) and follicular morphology, viability, antrum formation, follicle and oocyte diameter, growth rate, ultrastructural characteristics and cell proliferation were evaluated. The percentages of morphologically normal follicles and antrum formation were similar among groups. Follicular viability and oocyte diameter were similar between Follicle-Vit and Tissue-Vit. The follicular diameter and growth rate of Follicle-Vit were similar to the Control, while those of Tissue-Vit were significantly lower compared to the Control. Both vitrified groups had an augmented rate of granulosa cellular proliferation compared to Control. Secondary follicles can be successfully vitrified before or after isolation from the ovarian tissue without impairing their ability to survive and grow during in vitro culture.


Subject(s)
Ovarian Follicle/growth & development , Vitrification , Animals , Female , In Vitro Techniques , Sheep
6.
Zygote ; 23(1): 41-52, 2015 Feb.
Article in English | MEDLINE | ID: mdl-23941689

ABSTRACT

The role of activin-A in follicular development and on the mRNA expression levels of different genes in goat secondary follicles was evaluated. Goat secondary follicles (≥ 150 µm) were cultured for 18 days under control conditions or with the addition of either 50 or 100 ng/ml activin-A (Experiment 1). The mRNA levels for the genes that code for activin-A, ActR-IA, ActR-IB, ActR-IIA, ActR-IIB, follicle stimulating hormone receptor (FSH-R) and P450 aromatase were measured in each condition (Experiment 2). We observed that after 6 days of culture, the antrum formation rate was higher in cultures with added activin-A than in the cultured control (P < 0.05). The addition of 50 ng/ml activin-A increased the follicular growth rate in the final third of the culture (days 12-18), resulting in a higher percentage of meiosis resumption (P < 0.05). On day 6, the addition of activin-A (50 ng/ml) increased the levels of ActR-IA mRNA compared with the cultured control (P < 0.05). After 18 days, the addition of 50 ng/ml activin-A significantly increased the levels of its own mRNA compared with the non-cultured control. Moreover, this treatment reduced the mRNA levels of P450 aromatase in comparison with the cultured control (P < 0.05). Higher levels of P450 aromatase mRNA were found for both activin-A treatments compared with the non-cultured control (P < 0.05). No difference in estradiol levels was detected among any of the tested treatments. In conclusion, the addition of activin-A to culture medium stimulated early antrum formation as well as an increase in the daily follicular growth rate and the percentage of meiosis resumption.


Subject(s)
Activins/pharmacology , Ovarian Follicle/drug effects , Ovarian Follicle/physiology , Activin Receptors, Type I/genetics , Activin Receptors, Type II/genetics , Activins/genetics , Animals , Aromatase/genetics , Cells, Cultured , Estradiol/analysis , Estradiol/metabolism , Female , Gene Expression Regulation/drug effects , Goats , In Vitro Oocyte Maturation Techniques/methods , Ovarian Follicle/ultrastructure , Receptors, FSH/genetics
7.
Tissue Cell ; 46(6): 439-49, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25239757

ABSTRACT

Sildenafil is a potent and selective inhibitor of phosphodiesterase-5 (PDE5) and is considered first-line therapy for erectile dysfunction. Nowadays, Sildenafil is used extensively throughout the world on patients with pulmonary hypertension. However, few studies have evaluated the possible side effects of chronic Sildenafil treatment on the male reproductive system, specifically in the prostate. In the present study, it was demonstrated via morphological and ultrastructural analysis that chronic treatment with Sildenafil induced an enhancement of the glandular activity of the prostate. In addition, mice treated with Sildenafil showed a significant increase in testosterone serum levels. However, no statistically significant differences were observed in nitric oxide serum levels, or in sGC, eNOS, PSA and TGF-ß prostatic expression. In conclusion, the present study suggests that chronic use of Sildenafil does not cause evident prostatic damage, and therefore, can be used pharmacologically to treat a variety of disorders.


Subject(s)
Erectile Dysfunction/drug therapy , Piperazines/administration & dosage , Prostate/ultrastructure , Sulfonamides/administration & dosage , Animals , Erectile Dysfunction/blood , Erectile Dysfunction/pathology , Humans , Hypertension, Pulmonary/drug therapy , Hypertension, Pulmonary/pathology , Male , Mice , Mice, Inbred C57BL , Nitric Oxide/blood , Nitric Oxide Synthase Type III/blood , Prostate/drug effects , Prostate-Specific Antigen/blood , Purines/administration & dosage , Sildenafil Citrate , Testosterone/blood , Transforming Growth Factor beta/blood
8.
Int Immunopharmacol ; 23(1): 153-62, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25175917

ABSTRACT

Diethylcarbamazine citrate (DEC) is widely used to treat lymphatic filariasis and Tropical Pulmonary Eosinophilia. A number of studies have reported a possible role in the host immune system, but exactly how DEC exerts this effect is still unknown. The present study reports the effects of DEC pretreatment on NF-κB regulation using the pleurisy model induced by carrageenan. Swiss male mice (Mus musculus) were divided into four experimental groups: control (SAL); carrageenan (CAR); diethylcarbamazine (DEC) and curcumin (CUR). The animals were pretreated with DEC (50mg/kg, v.o), CUR (50mg/kg, i.p) or distilled water for three consecutive days before pleurisy. One way analysis of variance (ANOVA) was performed by Tukey post-hoc test, and values were considered statistically significant when p<0.05. DEC pretreatment reduced tissue damage and the production of inflammatory markers, such as NO, iNOS, PGE2, COX-2, and PARP induced by carrageenan. Similarly, a known inhibitor of NF-κB pathway (curcumin) was also able to reduce these parameters. Like curcumin, DEC prevents NF-κB activation by reducing NF-κB p65 phosphorylation and IκBα degradation. DEC prevented NF-κB activation via p38 MAPK, but did not interfere in the ERK pathway in this experimental model. However, further studies should be developed to confirm this hypothesis. These findings suggest that DEC could be a promising drug for inflammatory disorders, especially in pulmonary diseases such as Acute Lung Inflammation, due its high anti-inflammatory potential which prevents NF-κB activation.


Subject(s)
Anti-Inflammatory Agents/administration & dosage , Diethylcarbamazine/administration & dosage , Elephantiasis, Filarial/drug therapy , NF-kappa B/metabolism , Pleurisy/drug therapy , Pulmonary Eosinophilia/drug therapy , Animals , Carrageenan/toxicity , Curcumin/administration & dosage , Disease Models, Animal , Humans , Inflammation Mediators/metabolism , Male , Mice , Pleurisy/chemically induced , Signal Transduction/drug effects , Transcriptional Activation/drug effects , p38 Mitogen-Activated Protein Kinases/metabolism
9.
Mediators Inflamm ; 2014: 105120, 2014.
Article in English | MEDLINE | ID: mdl-24550603

ABSTRACT

Diethylcarbamazine (DEC) is an antifilarial drug with potent anti-inflammatory properties as a result of its interference with the metabolism of arachidonic acid. The aim of the present study was to evaluate the anti-inflammatory activity of DEC in a mouse model of acute inflammation (carrageenan-induced pleurisy). The injection of carrageenan into the pleural cavity induced the accumulation of fluid containing a large number of polymorphonuclear cells (PMNs) as well as infiltration of PMNs in lung tissues and increased production of nitrite and tumor necrosis factor-α and increased expression of interleukin-1ß, cyclooxygenase (COX-2), and inducible nitric oxide synthase. Carrageenan also induced the expression of nuclear factor-κB. The oral administration of DEC (50 mg/Kg) three days prior to the carrageenan challenge led to a significant reduction in all inflammation markers. The present findings demonstrate that DEC is a potential drug for the treatment of acute lung inflammation.


Subject(s)
Carrageenan/adverse effects , Diethylcarbamazine/chemistry , Gene Expression Regulation/drug effects , Lung Injury/chemically induced , Lung Injury/drug therapy , Administration, Oral , Animals , Anti-Inflammatory Agents/chemistry , Cyclooxygenase 2/metabolism , Inflammation , Interleukin-1beta/metabolism , Leukocytes/drug effects , Lipoxygenase Inhibitors/chemistry , Lung/metabolism , Male , Mice , Nitric Oxide Synthase Type II/metabolism , Pleurisy/chemically induced , Random Allocation
10.
Zygote ; 21(2): 125-8, 2013 May.
Article in English | MEDLINE | ID: mdl-22717039

ABSTRACT

Summary This study investigated the effect of three different culture media (α minimum essential medium (α-MEM), McCoy or TCM199 during the in vitro culture (IVC) of bovine isolated pre-antral follicles. Pre-antral follicles greater than 150 µm in size were isolated and cultured for 0 (control), 8 or 16 days in one of the abovementioned culture media. Follicles were evaluated for survival, growth and antrum formation at days 8 and 16. The results showed that TCM199 was the most suitable medium to preserve follicular viability and ultrastructure, resulting in the highest rates of antrum formation. In conclusion, TCM199 promotes the in vitro development of isolated pre-antral follicles without hampering follicular functionality by sustaining in vitro growth and antrum formation.


Subject(s)
Cell Survival/drug effects , Culture Media/pharmacology , In Vitro Oocyte Maturation Techniques , Ovarian Follicle/cytology , Ovarian Follicle/drug effects , Animals , Cattle , Cells, Cultured , Female , Organic Chemicals/pharmacology , Ovarian Follicle/ultrastructure
11.
Cardiovasc Pathol ; 22(1): 81-90, 2013.
Article in English | MEDLINE | ID: mdl-22795892

ABSTRACT

BACKGROUND: Atherosclerotic cardiovascular disease is a chronic inflammatory condition. Thiazolidinediones (TZDs) are used to enhance sensitivity to insulin and have demonstrated a protective effect over a variety of cardiovascular markers and risk factors. Controversially, the TZDs are associated with the development of heart failure. Thus, lines of research have invested in the search for new molecules in order to obtain more selective and less harmful treatment alternatives for the pathogenesis of atherosclerosis and its risk factors. METHODS: Animals were fed a diet rich in fat for 10 weeks. In the last 2 weeks, animals received either pioglitazone, LPSF/GQ-02, or LPSF/GQ-16 daily through gavage. At the end of the treatment, blood was collected for biochemical analysis and the aortas were dissected for subsequent analyses. RESULTS: No changes in the blood lipid profile were found following the use of the drugs in comparison to the control. However, the new thiazolidine derivatives were more efficient in improving insulin resistance in comparison to pioglitazone and the control group. Morphometric analyses revealed that neither pioglitazone nor LPSF/GQ16 led to satisfactory effects over atherosclerosis. However, LPSF/GQ-02 led to a reduction in area of the atherosclerotic lesions. Ultrastructural analyses revealed extensive degeneration of the endothelium and an increase in apoptotic cells in the subendothelial space following the use of pioglitazone and LPSF/GQ-16. However, LPSF/GQ-02 caused minimal cell alterations in the aortic endothelium. Regarding markers, endothelial nitric oxide synthase (eNOS) and matrix metalloproteinase 9 (MMP-9), LPSF/GQ-16, and pioglitazone exerted similar effects, increasing the expression of MMP-9, and had no effect on the expression of eNOS compared with the control group. On the other hand, LPSF/GQ-02 was effective in reducing the expression of MMP-9 and increased eNOS significantly. CONCLUSIONS: The results suggest that the new thiazolidine derivative LPSF/GQ-02 is a promising candidate for the treatment of atherosclerosis.


Subject(s)
Aorta/drug effects , Aortic Diseases/drug therapy , Atherosclerosis/drug therapy , Cardiovascular Agents/pharmacology , Receptors, LDL/deficiency , Thiazolidinediones/pharmacology , Thiazolidines/pharmacology , Animals , Aorta/metabolism , Aorta/ultrastructure , Aortic Diseases/genetics , Aortic Diseases/pathology , Apoptosis/drug effects , Atherosclerosis/blood , Atherosclerosis/genetics , Atherosclerosis/pathology , Blood Glucose/drug effects , Blood Glucose/metabolism , Blotting, Western , Cardiovascular Agents/toxicity , Disease Models, Animal , Endothelium, Vascular/drug effects , Endothelium, Vascular/metabolism , Endothelium, Vascular/pathology , Immunohistochemistry , Insulin/blood , Insulin Resistance , Lipids/blood , Matrix Metalloproteinase 9/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Microscopy, Electron, Transmission , Nitric Oxide Synthase Type III/metabolism , Pioglitazone , Plaque, Atherosclerotic , Receptors, LDL/genetics , Thiazolidinediones/toxicity , Thiazolidines/toxicity , Time Factors
12.
Micron ; 40(8): 845-50, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19608425

ABSTRACT

Vardenafil citrate is a potent vasodilator used in the treatment of patients with erectile dysfunction. Its mechanism of action is based on the selective inhibition of phosphodiesterase-5 (PDE5), specific to guanosine 3',5'-cyclic monophosphate (cGMP). Recently, chronic treatment with Vardenafil has been successfully used in cases of pulmonary hypertension and, despite being used in high doses for long periods, little is known about its effects on other systems. In the present study, female mice were treated daily with 5 mg/kg Vardenafil for 4 weeks, after which the ovaries were collected for morphological analyses and sera were collected for biochemical assays. This study found that treatment with Vardenafil decreased HDL serum levels and the number of antral follicles as well as induced lesser lipid content in luteal cells, suggesting that high levels of cGMP may affect follicle development.


Subject(s)
Enzyme Inhibitors/pharmacology , Imidazoles/pharmacology , Luteal Cells/drug effects , Luteal Cells/ultrastructure , Ovarian Follicle/drug effects , Phosphodiesterase 5 Inhibitors , Piperazines/pharmacology , Animals , Enzyme Inhibitors/administration & dosage , Female , Histocytochemistry , Imidazoles/administration & dosage , Lipoproteins, HDL/analysis , Mice , Microscopy, Electron, Transmission , Ovarian Follicle/growth & development , Piperazines/administration & dosage , Serum/chemistry , Sulfones/administration & dosage , Sulfones/pharmacology , Triazines/administration & dosage , Triazines/pharmacology , Vardenafil Dihydrochloride
13.
Micron ; 39(5): 580-6, 2008 Jul.
Article in English | MEDLINE | ID: mdl-17681769

ABSTRACT

Diethylcarbamazine (DEC) has been proven to be highly effective against lymphatic filariasis, although its effect on vertebrate cells remains uncertain. Mice Leydig cells after treatment with 200mg/kg of DEC for 12 days showed numerous lipid droplets, degenerated mitochondria, residual bodies and several giant whorl-like smooth endoplasmic reticulum, some of them encircling large lipids droplets. Treatment with lower dosages showed similar alterations on Leydig cells and the morphological effects decreased directly proportional to the drug concentration. Serum testosterone levels were significantly lower only in 200 mg/kg DEC-treated group when compared to the controls. However, no significant changes were observed in the pregnancy rates and offspring number of DEC-treated male-mated female mice in any doses studied. The results obtained in the present study are consistent with the hypothesis that DEC has some effects on mice Leydig cells, although they were not sufficient enough to interfere with the rodent fertility.


Subject(s)
Diethylcarbamazine , Filaricides , Leydig Cells , Testis/cytology , Testis/drug effects , Testosterone/metabolism , Animals , Diethylcarbamazine/administration & dosage , Diethylcarbamazine/pharmacology , Dose-Response Relationship, Drug , Female , Fertility , Filaricides/administration & dosage , Filaricides/pharmacology , Leydig Cells/drug effects , Leydig Cells/metabolism , Leydig Cells/ultrastructure , Lipids/analysis , Male , Mice , Microscopy, Electron, Transmission , Pregnancy , Testis/ultrastructure
SELECTION OF CITATIONS
SEARCH DETAIL
...